Cancer Chemother Pharmacol. 2023 Mar 26. doi: 10.1007/s00280-023-04522-x. Online ahead of print.
NO ABSTRACT
PMID:36967405 | DOI:10.1007/s00280-023-04522-x
Categories
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
